Parkinson disease, brain volumes, and subthalamic nucleus stimulation

Neurology

Volumn 64, Issue 9, 2005, Pages 1598-1604

  Bonneville, F ^a   Welter, M L ^a   Elie, C ^a   Tezenas Du Montcel, S ^a   Hasboun, D ^a   Menuel, C ^a   Houeto, J L ^a   Bonnet, A M ^a   Mesnage, V ^a   Pidoux, B ^a   Navarro, S ^a   Cornu, P ^a   Agid, Y ^a   Dormont, D ^a,b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN DEPTH STIMULATION; CAUDATE NUCLEUS; CONTROLLED STUDY; DAILY LIFE ACTIVITY; FEMALE; GLOBUS PALLIDUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MESENCEPHALON; MOTOR DYSFUNCTION; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PREDICTION; PRIORITY JOURNAL; PUTAMEN; RED NUCLEUS; STEREOTAXIS; SUBTHALAMIC NUCLEUS;

ACTIVITIES OF DAILY LIVING; AGE OF ONSET; AGED; ANTIPARKINSON AGENTS; ATROPHY; BRAIN; BRAIN MAPPING; DEEP BRAIN STIMULATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSON DISEASE; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; STATISTICS; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

EID: 20944447426     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000160401.24880.83     Document Type: Article

References (44)

1. Lang AE, Lozano AM. Parkinson's disease. First of two parts. N Engl J Med 1998:339:1044-1053.
2. Agid Y. Parkinson's disease: pathophysiology. Lancet 1991;337:1321-1324.
3. Lang AE, Lozano AM. Parkinson's disease. Second of two parts. N Engl J Med 1998:339:1130-1143.
4. Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998;339:1105-1111.
5. Houeto JL, Damier P, Bejjani PB, et al. Subthalamic stimulation in Parkinson disease: a multidisciplinary approach. Arch Neurol 2000;57:461-465.
6. Charles PD, Van Blercom N, Krack P, et al. Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology 2002;59:932-934.
7. Welter ML, Houeto JL, Tezenas du Montcel S, et al. Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain 2002;125:575-583.
8. Houeto JL, Welter ML, Bejjani BP, et al. Subthalamic stimulation in Parkinson disease: intraoperative predictive factors. Arch Neurol 2003;60:690-694.
9. Lanotte MM, Rizzone M, Bergamasco B, Faccani G, Melcarne A, Lopiano L. Deep brain stimulation of the subthalamic nucleus: anatomical, neurophysiological, and outcome correlations with the effects of stimulation. J Neurol Neurosurg Psychiatry 2000;72:53-58.
10. Hamel W, Fietzek U, Morsnowski A, et al. Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: evaluation of active electrode contacts. J Neurol Neurosurg Psychiatry 2003;74:1036-1046.
11. Desaloms JM, Krauss JK, Lai EC, Jankovic J, Grossman RG. Posteroventral medial pallidotomy for treatment of Parkinson's disease: preoperative magnetic resonance imaging features and clinical outcome. J Neurosurg 1998;89:194-199.
12. Durif F, Pollak P, Hommel M, et al. Relationship between levodopa-independent symptoms and central atrophy evaluated by magnetic resonance imaging in Parkinson's disease. Eur Neurol 1992;32:32-36.
13. Starkstein SE, Leiguarda R. Neuropsychological correlates of brain atrophy in Parkinson's disease: a CT-scan study. Mov Disord 1993;8:51-55.
14. Hu MT, White SJ, Chaudhuri KR, Morris RG, Bydder GM, Brooks DJ. Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline. J Neural Transm 2001;108:571-580.
15. Alegret M, Junque C, Pueyo R, et al. MRI atrophy parameters related to cognitive and motor impairment in Parkinson's disease. Neurologia 2001;16:63-69.
16. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
17. Fahn S, Elton R, and members of UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden C, Calne D, Goldstein M, eds. Recent developments in Parkinson's disease. Florham Park: Macmillan Healthcare Information, 1987:153-163.
18. Lozano AM, Lang AE, Galvez-Jimenez N, et al. Effect of GPi pallidotomy on motor function in Parkinson's disease [published erratum appears in Lancet 1996;348:1108]. Lancet 1995;346:1383-1387.
19. Mattis S. Dementia Rating Scale. Odessa, FL: Psychological Assessment Resources, 1988.
20. Pillon B, Ardouin C, Damier P, et al. Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease. Neurology 2000;55:411-418.
21. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389.
22. Langston JW, Widner H, Goetz CG, et al. Core Assessment Program for Intracerebral Transplantations (CAPIT). Mov Disord 1992;7:2-13.
23. Cointepas Y, Mangin J, Garnero L, Poline J, Benali H. Brain VISA: software platform for visualization and analysis of multi-modality brain data. Neuroimage 2001;13:S98.
24. Schulz JB, Skalej M, Wedekind D, et al. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann Neurol 1999;45:65-74.
25. Whitwell JL, Crum WR, Watt HC, Fox NC. Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging. AJNR Am J Neuroradiol 2001;22:1483-1489.
26. Shrout, PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979;2:420-428.
27. Bejjani BP, Dormont D, Pidoux B, et al. Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. J Neurosurg 2000;92:615-625.
28. Ghaemi M, Hilker R, Rudolf J, Sobesky J, Heiss WD. Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging. J Neurol Neurosurg Psychiatry 2002;73:517-523.
29. O'Neill J, Schuff N, Marks WJ Jr, Feiwell R, Aminoff MJ, Weiner MW. Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease. Mov Disord 2002;17:917-927.
30. Camicioli R, Moore MM, Kinney A, Corbridge E, Glassberg K, Kaye JA. Parkinson's disease is associated with hippocampal atrophy. Mov Disord 2003;18:784-790.
31. Lisanby SH, McDonald WM, Massey EW, et al. Diminished subcortical nuclei volumes in Parkinson's disease by MR imaging. J Neural Transm (Suppl) 1993;40:13-21.
32. Double KL, Halliday GM, McRitchie DA, Reid WG, Hely MA, Morris JG. Regional brain atrophy in idiopathic Parkinson's disease and diffuse Lewy body disease. Dementia 1996;7:304-313.
33. Bonnet AM, Loria Y, Saint-Hilaire MH, Lhermitte F, Agid Y. Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions? Neurology 1987;37:1539-1542.
34. Schrag A, Good CD, Miszkiel K, et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2000;54:697-702.
35. Warmuth-Metz M, Naumann M, Csoti I, Solymosi L. Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. Arch Neurol 2001;58:1076-1079.
36. Tarsy D, Apetauerova D, Ryan P, Norregaard T. Adverse effects of subthalamic nucleus DBS in a patient with multiple system atrophy. Neurology 2003;61:247-249.
37. Pinter MM, Alesch F, Murg M, Helscher RJ, Binder H. Apomorphine test: a predictor for motor responsiveness to deep brain stimulation of the subthalamic nucleus. J Neurol 1999;246:907-913.
38. Krack P, Dowsey PL, Benabid AL, et al. Ineffective subthalamic nucleus stimulation in levodopa-resistant postischemic parkinsonism. Neurology 2000;54:2182-2184.
39. Hugues AJ, Daniel SE, Blankon S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993;50:140-148.
40. Pahapill PA, Lozano AM. The pedunculopontine nucleus and Parkinson's disease. Brain 2000;123:1767-1783.
41. Hirsch EC, Graybiel AM, Duyckaerts C, Javoy-Agid F. Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. Proc Natl Acad Sci USA 1987;84:5976-5980.
42. Brenneis C, Seppi K, Schocke MF, et al. Voxel-based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy. Mov Disord 2003;18:1132-1138.
43. Bugiani O, Perdelli F, Salvarani S, Leonardi A, Mancardi GL. Loss of striatal neurons in Parkinson's disease: a cytometric study. Eur Neurol 1980;19:339-344.
44. McNeill TH, Brown SA, Rafols JA, Shoulson I. Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease. Brain Res 1988;455:148-152.